Physician profile
Christopher R Hancock
NPI 1922128255
$22,982.38
in general payments reported to CMS, 2019-2025
17 companies · $13K in 2025
The $13K reported for 2025 was more than what 97% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $240 · 2021: $171 · 2022: $1,441 · 2023: $2,998 · 2024: $4,436 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $1,600 · Food and Beverage: $1,112 · Education: $33.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,007.00 |
| Travel and Lodging | $1,599.96 |
| Food and Beverage | $1,112.48 |
| Education | $33.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare LLC | $11,926.29 | 2023-2025 | |
| Biogen, INC. | $9,378.55 | 2021-2025 | Aduhelm |
| Boston Scientific Corporation | $259.86 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Amgen INC. | $245.00 | 2023-2024 | Krystexxa, Evenity |
| Abbvie INC. | $179.00 | 2023-2025 | |
| Lilly USA, LLC | $138.34 | 2024-2025 | Kisunla, Amyvid |
| Abbott Laboratories | $133.84 | 2019 | |
| Novo Nordisk INC | $118.46 | 2024 | Wegovy |
| Pfizer INC. | $117.00 | 2020 | |
| Medtronic Vascular, INC. | $100.42 | 2020 | |
| Seqirus USA INC | $92.72 | 2019 | |
| Conformis, INC. | $78.95 | 2019 | |
| Philips North America LLC | $72.60 | 2022 | |
| Janssen Biotech, INC. | $71.80 | 2019 | |
| Eisai INC. | $26.73 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $25.59 | 2022-2023 | Cholbam |
| Merck Sharp & Dohme LLC | $17.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.